Showing results (281-290 of 909) with videos related to

Sort By:
Pageof 91
Journal of Hypertension|September 19, 2014
Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart diseaseSusan Cheng, Amil M Shah, Juan Pablo Albisu, et al.
Journal of the American Heart Association|January 6, 2018
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive PatientsRobert D Brook, Niko Kaciroti, George Bakris, et al.
The American Journal of Medicine|August 12, 2019
Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment TrialPhillip H Lam, Milton Packer, Gregg C Fonarow, et al.
American Journal of Hypertension|September 15, 2004
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertensionKenneth A Jamerson, George L Bakris, Chuan-Chuan Wun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2020
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenoneRajiv Agarwal, Stefan D Anker, George Bakris, et al.
European Journal of Heart Failure|October 14, 2015
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitorsBertram Pitt, George L Bakris, David A Bushinsky, et al.
The American Journal of Medicine|November 29, 2017
Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS InhibitorsMatthew R Weir, David A Bushinsky, Wade W Benton, et al.
Pharmacoeconomics|September 9, 2018
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with HyperkalemiaMark Bounthavong, Javed Butler, Chantal M Dolan, et al.
European Heart Journal|June 22, 2015
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trialNicolas Girerd, Tim Collier, Stuart Pocock, et al.
International Journal of Cardiology. Heart & Vasculature|July 14, 2021
A preliminary study on the relationship between sleep, depression and cardiovascular dysfunction in a 4 sample populationAdrienne-Denise V Bilbao, Jennifer Goldschmied, Angela Jang, et al.
Pageof 91